Medical treatment of depression in children and adolescents;Medikamentöse Therapie der Depression bei Kindern und Jugendlichen

Praxis der Kinderpsychologie und Kinderpsychiatrie

Volumn 56, Issue 3, 2007, Pages 224-233

  Kölch, Michael ^a   Fegert, Jörg M ^b  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b NONE

Author keywords

Antidepressants; Depression in childhood and adolescence; Evidence based treatment

Indexed keywords

EID: 34147206555     PISSN: 00327034     EISSN: None     Source Type: Journal    
DOI: 10.13109/prkk.2007.56.3.224     Document Type: Article

References (29)

1. AACAP American Academy of Child and Adolescent Psychiatry (AACAP) (1998). Practice Parameters for the Assessment and Treatment of Children and Adolescents with Depressive Disorders, http://www.aacap.org/galleries/ PracticeParameters/Depress.pdf (Zugang verifiziert 10.10.2006)
2. Amitai, Y., Frischer, H. (2006). Excess fatality from desipramine in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 45. 54-60.
3. Birmaher, B., Ryan, N. D., Williams, D. E., Brent, D. A., Kaufmann, J. (1996). Childhood and adolescent depression: A review of the past 10 years, part 1. J Am Acad Child Adolesc Psychiatry, 35, 1427-1439.
4. EMEA (2006). EMEADoc.Ref.EMEA/202554/2006
5. Dt.Ges.f. Kinder- und Jugendpsychiatrie und Psychotherapie u.a. (DGKJP) (Hrsg.). Leitlinien zur Diagnostik und Therapie von psychischen Störungen im Säuglings-, Kindes- und Jugendalter. 2. überarbeitete Auflage 2003. Köln: Deutscher Ärzte Verlag.
6. Dt.Ges.f. Kinder- und Jugendpsychiatrie und Psychotherapie u. a. (DGKJP) (Hrsg.). Leitlinien zur Diagnostik und Therapie von psychischen Störungen im Säuglings-, Kindes- und Jugendalter. 3. überarbeitete Auflage 2006, im Druck.
7. Doi, Y., Roberts, R.E., Takeuchi, K., Suzuki, S. (2001). Multiethnic Comparison of Adolescent Major Depression Based on the DSM-IV Criteria in a U.S.-Japan Study.Journal of the American Academy of Child & Adolescent Psychiatry, 40, 1308-1315.
8. Europäische Kommission (2005). Grünbuch Die psychische Gesundheit der Bevölkerung verbessern - Entwicklung einer Strategie für die Förderung der psychischen Gesundheit in der Europäischen Union.
9. Fegert, J. M., Herpertz-Dahlmann, B. (2004) Zum Einsatz von selektiven Serotoninwiederaufnahmehemmern (SSRI) bei depressiven Kindern und Jugendlichen. Z. Kinder- Jugendpsychiatr., 32, 74-75.
10. Fegert, J. M., Kölch, M., Zito, J. M., Glaeske, G., Janhsen, K. (2006). Antidepressant Use in Children and Adolescents in Germany. Journal of Child and Adolescent Psychopharmacology, 16, 197-206.
11. Fegert, J. M. (2004). Depressionsbehandlung mit SSRI in der Kinder- und Jugendpsychiatrie - Ein Forschungs- oder ein Informationsdebakel? Nervenheilkunde, 23, 60-64.
12. Hazell, P., O'Connell, D., Heathcote, D., Robertson, L. et al. (1995). Efficacy of Tricyclic Drugs in Treating Child and Adolescent Depression: a Meta-analysis, BMJ, 310. 897-901.
13. Hammad, T. A. (2004). Results of the analysis of suicidality in pediatric trial of newer antidepressants. FDA Center of for Drug Evaluation and Research. Sep 13. 2004, www.fda.gov/ohrms/dockets/ac/04/slides/2004-4065S1_08_FDA- Hammad_files/frame.htm
14. Hammad, T.A., Laughren, T., Racoosin, J. (2006). Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry, 63, 332-339.
15. Harrington, R. (2001). Depression, suicide and deliberate self-harm in adolescence, Britisch Medical Bulletin, 57, 47-60.
16. Kölch, M., Bücheler, R., Fegert, J. M., Gleiter, C. H. (2006). Johanniskraut - eine evidenzbasierte Alternative in der Behandlung kindlicher und juveniler Depressionen? Eine Übersicht zu Indikationen, Wirkung, Evidenz und Verschreibungspraxis Johanniskraut. Psychopharmakotherapie, 13, 95-99.
17. Klein, F.D. (2006). The flawed basis for FDA post-marketing safety decisions: the example of anti-depressants and children. Neuropsychopharmacology, 31, 689-699.
18. Kratochvil, C. J., Vitiello, B., Walkup, J., Emslie, G., Waslick, B. D., Weller, E. B., Burke, W. J., March, J. S. (2006). Selective Serotonin Reuptake Inhibitors in pediatric Depression: Is the Balance Between Benefits and Risks Favorable? J Child Adolesc Psychopharmacology, 16, 11-24.
19. Mosholder, A. D., Willy, M. (2006). Suicidal Adverse Events in Pediatric Randomized, Controlled Clinical Trials of Antidepressant Drugs Are Associated with Active Drug Treatment: A Meta-Analysis. J Child Adolesc Psychopharmacology, 16, 25-32.
20. National Institute for Clinical Excellence (2005). Depression in Children and Young People Identification and management in primary, community and secondary care, National Clinical Practice Guideline Number 28, developed by National Collaborating Centre for Mental Health commissioned by the National Institute for Clinical Excellence published by The British Psychological Society & The Royal College of Psychiatrists.
21. Posner K.; Suicidality Classification Project, http://www.fda.gov/cder/ drug/antidepressants/classificationProject.htm
22. Safer, D. J., Zito, J. M. (2006). Treatment-Emergent Adverse Events from Selective Serotonin Reuptake Inhibitors by Age Group: Children versus Adolescents. J Child Adolesc Psychopharmacology, 16, 159-169.
23. Schepker, R., Lippert, H.-D., Kölch, M., Fegert J. M. (2006). Die Crux mit der gerichtlichen Sachkunde, Kommentar zum SSRI-Absetz-Urteil des SG Dresden und zunehmenden Eingriffen in die ärztliche Therapiefreiheit, Zeitschrift für Kinder- und Jugendpsychiatrie (eingereicht).
24. The Treatment for Adolescents with Depression Study (TADS) Team (2003). The Treatment for Adolescents With Depression Study (TADS): Rationale, Design, and Methods. J. Am. Acad. Child Adolesc Psychiatry, 42, 531-542.
25. The Treatment for Adolescents with Depression Study (TADS) Team (2004).Fluoxetine, Cognitive-Behavioral Therapy, and Their Combination for Adolescents With Depression Treatment for Adolescents With Depression Study (TADS) Randomized Controlled Trial. JAMA, 292, 807-820.
26. The Treatment for Adolescents with Depression Study (TADS) Team (2005). The Treatment for Adolescents With Depression Study (TADS): Demographic and Clinical Characteristics, J. Am. Acad. Child Adolesc Psychiatry, 44, 28-40
27. Weissmann, M. M., Wolk, S., Goldstein, R. B., Moreau, D., Adams, P., Greenwald, S., Klier, C. M., Ryan, N. D., Dahl, R. E., Wickramaratne, P. (1999). Depressed adolescents grown up. JAMA 281, 1707-1713.
28. Whittington, C. J., Kendall, T., Fonagy, P., Cotrell, D., Cotgrove, A., Boddinton, E. (2004). Selective Serotonin Reuptake Inhibitors in Childhood Depression: Systematic Review of Published versus Unpublished Data. Lancet 362, 1342-1345.
29. WHO, World Health Report 2001, p. 11. http://www.who.int/whr/2001. (Zugang verifiziert 10.10.2006)